Imperial and Crick Cancer Drug Spinout Raises 90M Pounds to Begin Clinical Development
July 09, 2024
July 09, 2024
LONDON, England, July 9 (TNSres) -- Imperial College-London issued the following news:
* * *
Myricx Bio is bringing new therapeutic possibilities to the highly promising area of antibody-drug conjugates for treating cancer.
* * *
By Ian Mundell
Myricx Bio, a cancer therapy spinout based on research carried out at Imperial and the Francis Crick Institute, has raised pound sterling90 million ($114 million) in investment to move its n . . .
* * *
Myricx Bio is bringing new therapeutic possibilities to the highly promising area of antibody-drug conjugates for treating cancer.
* * *
By Ian Mundell
Myricx Bio, a cancer therapy spinout based on research carried out at Imperial and the Francis Crick Institute, has raised pound sterling90 million ($114 million) in investment to move its n . . .